Why Us?
Industry Veterans Turning Innovation Into Impact
Who We Are
At Twenty Seven Labs, we are a boutique consulting firm built by industry veterans from Chronus Health, IBM Research, and leading biotech companies.
With decades of proven expertise in microfluidics, biosensors, surface chemistry, and point-of-care diagnostics, we specialize in guiding innovative diagnostic technologies from early feasibility to clinical implementation.
Our team has successfully developed breakthrough platforms, including complete blood count (CBC) and comprehensive metabolic panel (CMP) testing systems, bringing a unique blend of technical depth and commercialization experience.
See what we do →
Our Facilities
From early-stage research to production-ready processes, we have the infrastructure to take your idea from concept to mature, repeatable workflows.
Our Team
Ashish V. Jagtiani, Ph.D.
Co-Founder & Partner
Deep-tech innovation expert and medical device entrepreneur with 15+ years in diagnostics, biosensing, and microfluidics.
Former Co-founder and CTO of Chronus Health, where he led development of next-generation blood testing platforms and secured $25M+ in funding.
Former IBM Research engineer with multiple patents in biosensor technologies. Expertise in translating early-stage science into clinically impactful medical devices.
Rajinder Bhatia, Ph.D.
Co-Founder & Partner
Seasoned chemistry and assay development expert with 20+ years in IVD, specializing in immunoassays, infectious diseases, and point-of-care diagnostics.
Former leadership roles at Chronus Health and XIP Diagnostics, directing assay development from feasibility to clinical validation.
Deep expertise in surface chemistry, bioconjugation, and biosensor functionalization. Proven track record building and scaling IVD assays across multiple platforms.